The FDA’s Latest Warning: A Good Reminder Regarding the Litigation Risks of Off-Label Use
Last week, the FDA issued a warning against the use of robotic surgery for mastectomy and other cancer-related procedures. The warning stated, in relevant part, “To date, the FDA has not granted marketing authorization for any robotically-assisted surgical device for use in the United States for the prevention or treatment of cancer, including breast cancer.”…
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed